BEAM:BMV
Beam Therapeutics Inc
MX$453,00
arrow_downward
-0,07%(-0,31) 1D
8 ຕ.ລ., 7 ໂມງ 30 ນາທີ 20 ວິນາທີ GMT-6 · MXN
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BEAM...
Open
MX$453,00
High
MX$453,00
Low
MX$453,00
Mkt. cap
2,52 ຕື້
Avg. vol.
14,00
Volume
7,00
52-wk high
MX$663,44
52-wk low
MX$384,79
No. of employees
540
Open
MX$453,00
High
MX$453,00
Low
MX$453,00
Mkt. cap
2,52 ຕື້
Avg. vol.
14,00
Volume
7,00
52-wk high
MX$663,44
52-wk low
MX$384,79
No. of employees
540
News stories
From web sources and news partners
Dealroom
·
19 ນາທີກ່ອນ
Basel Medical raises $7.98M in registered direct offering on Nasdaq
Forbes
·
14 ນາທີກ່ອນ
The S&P 500 Yields Barely 1%. Income Investors Need A New Playbook
Simply Wall Street
·
5 ນາທີກ່ອນ
Solstice Advanced Materials (SOLS) On Metropolis Settlement And Why Valuation Still Looks Debatable
Yahoo Finance
·
20 ນາທີກ່ອນ
Third-Quarter Earnings Season Begins Next Week and May Deliver Very Good News for the Market
Profile
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks. Wikipedia
About Beam Therapeutics Inc